Crossref
Tovorafenib: A novel B‑RAF inhibitor for the treatment of pediatric low‑grade glioma (Review)
World Academy of Sciences Journal · 20.05.2026 · 8 (4) · 1-9
DOI: 10.3892/wasj.2026.480 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Academy of Sciences Journal, online erschienen am 20.05.2026. Verfasst von Hyma Mandapaka und 1 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mandapaka, H., & De, S. (2026). Tovorafenib: A novel B‑RAF inhibitor for the treatment of pediatric low‑grade glioma (Review). World Academy of Sciences Journal, 8(4), 1-9. https://doi.org/10.3892/wasj.2026.480
Vancouver
Mandapaka H, De S. Tovorafenib: A novel B‑RAF inhibitor for the treatment of pediatric low‑grade glioma (Review). World Academy of Sciences Journal. 2026;8(4):1-9. doi:10.3892/wasj.2026.480
BibTeX
@article{Mandapaka2026,
author = {Mandapaka, Hyma and De, Surya},
title = {Tovorafenib: A novel B‑RAF inhibitor for the treatment of pediatric low‑grade glioma (Review)},
journal = {World Academy of Sciences Journal},
year = {2026},
volume = {8},
number = {4},
pages = {1--9},
doi = {10.3892/wasj.2026.480}
}
EUVIMED